Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017040841) METHODS OF ADMINISTERING ELAGOLIX
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/040841 International Application No.: PCT/US2016/049979
Publication Date: 09.03.2017 International Filing Date: 01.09.2016
IPC:
A61K 31/4178 (2006.01) ,A61K 31/496 (2006.01) ,A61K 31/513 (2006.01) ,A61K 31/565 (2006.01) ,A61P 15/00 (2006.01)
[IPC code unknown for A61K 31/4178][IPC code unknown for A61K 31/496][IPC code unknown for A61K 31/513][IPC code unknown for A61K 31/565][IPC code unknown for A61P 15]
Applicants:
ABBVIE INC. [US/US]; 1 North Waukegan Road North Chicago, Illinois 60064, US
Inventors:
GOSS, Sandra L.; US
KLEIN, Cheri E.; US
NG, Juki Wing-Keung; US
SALEM, Ahmed; US
Agent:
JOHANNES, Laura; US
AHMED, Aamer; US
BAUDE, Eric J.; US
CHEN, Portia; US
CORBIN, Johanna; US
GESICKI, Glen J.; US
MANZARI, Oona A.; US
STEELE, Gregory W.; US
SUN, Changxia; US
WARD, Michael J.; US
ZHANG, Xu; US
Priority Data:
62/213,00001.09.2015US
Title (EN) METHODS OF ADMINISTERING ELAGOLIX
(FR) MÉTHODES D'ADMINISTRATION D’ÉLAGOLIX
Abstract:
(EN) The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole.
(FR) La présente invention concerne l'utilisation d'antagonistes du récepteur de GnRH utilisés dans le traitement de l'endométriose ou de fibromes utérins. En particulier, la présente invention concerne une méthode pour traiter l'endométriose ou des fibromes utérins, ladite méthode consistant à administrer de l'élagolix, et pouvant également consister à co-administrer la rifampicine ou le kétoconazole.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)